Analyst picks & changes
Analyst picks & changes
| Company | Bank | Analyst | Coverage | Opinion | Wk chg | 5/9 cls |
| Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) | Cowen | Nicholas Bishop | Downgrade | Market perform (from outperform) | -25% | $32.62 |
| Bishop also lowered his target to $36 from $85 after Aegerion reported 1Q14 sales of Juxtapid | ||||||
